Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

Clinical trial NCT01188577 · COMPLETED

Trial details

NCT number: NCT01188577
Sponsor: Amphastar Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Asthma Bronchospasm Wheezing Shortness of Breath

Start date: 2010-08-01
Primary completion: 2010-09-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.